U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160426) titled 'Study of Protection And Repair of Endothelial-glycocalyx in Sepsis' on Aug. 29.
Brief Summary: Sepsis damages the blood vessel lining and its protective "glycocalyx," contributing to organ failure and death. This pilot, randomized, blinded study will test whether giving fresh frozen plasma (FFP)-either as intermittent boluses or as a continuous infusion-protects or repairs the glycocalyx compared with look-alike placebo fluid (lactated Ringer's with multivitamins), and whether this leads to better clinical outcomes. We will measure blood and urine biomarkers of glycocalyx injury and track organ support needs, ICU/hospital-free days,...